Sinotherapeutics Inc. (688247.SH) plans to launch a restricted stock incentive plan for 2025.

Xuantai Pharmaceuticals (688247.SH) announced its 2025 Restricted Stock Incentive Plan (Draft), planning to grant up to 6.23 million shares to incentive recipients, accounting for approximately 1.37% of the total share capital of the company at the time of the announcement of the incentive plan draft. Of these, up to 4.988 million shares will be granted for the first time, to not more than 64 incentive recipients, at a grant price of 5.71 yuan per share.